Apex, North Carolina
United States
13
2025-06-19
The entities that hold a legal rights for patent applications filed by inventor Bisi John E.:
John E. Bisi from Apex, US has applied for patents for these inventions. The list has both pending applications and granted patents:
CYCLIN-DEPENDENT KINASE 2 INHIBITORS FOR MEDICAL TREATMENT
#2 | 2023-08-03ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIBITOR COMPOUNDS TO TREAT RB-POSITIVE TUMORS
#3 | 2023-05-11Treatment of EGFR-Driven Cancer with Fewer Side Effects
#4 | 2022-06-09Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors
#5 | 2021-02-04TREATMENT OF CANCERS HAVING DRIVING ONCOGENIC MUTATIONS
#6 | 2020-01-23Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors
#7 | 2019-12-12Treatment of EGFR-driven cancer with fewer side effects
#8 | 2019-05-23Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat Rb-positive tumors
#9 | 2019-01-31Treatment of Rb-negative tumors using topoisomerase with cyclin dependent kinase 4/6 inhibitors
#10 | 2017-08-31Treatment Of RB-Negative Tumors Using Topoisomerase Inhibitors In Combination With Cyclin Dependent Kinase 4/6 Inhibitors
#11 | 2017-06-29Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat RB-positive tumors
#12 | 2013-11-14Protection of renal tissues from ischemia through inhibition of the proliferative kinases CDK4 and CDK6
#13 | 2011-09-15HEMATOPOIETIC PROTECTION AGAINST CHEMOTHERAPEUTIC COMPOUNDS USING SELECTIVE CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS
1914476 ⎘